NATCO Pharma LimitedNSE: NATCOPHARM

Press Release Feb 04 2023

· Issued by NATCO Pharma Limited

Filed with NSE ·

Natco Pharma Limited has informed the Exchange regarding a press release dated February 04, 2023, titled "USFDA COMPLETES INSPECTION OF NATCO s VIZAG FORMULATION FACILITY".

View Attachment

6ix hasn’t read this filing yet.

NATCO Pharma Limited on 6ix

Earlier from NATCO Pharma

Later from NATCO Pharma

All NATCO Pharma news releases